Sat.Oct 05, 2024 - Fri.Oct 11, 2024

article thumbnail

Concern over ‘incorrect and misleading’ pharmacy figures

The Pharmacist

Concern has been raised over what have been described as 'incorrect and misleading' figures released today by the NHS Business Services Authority (NHSBSA) which suggest a record number of active dispensing contractors in several years. New data published by the NHSBSA claim that 2023/24 saw the 'highest number of active dispensing contractors since 2015/16'.

107
107
article thumbnail

Men won all the science Nobels this year. There’s an even bigger problem.

STAT

Since the Nobel Prizes were created in 1901, just 24 women have received awards in the sciences. This year, that number stayed the same: All seven laureates in physics , chemistry , and physiology or medicine were men.  Some scientists have expressed frustration about the lack of women in this year’s awardees, particularly the omission of two women who contributed to the work honored for the prize in physiology or medicine.

363
363
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The 2024 PharmaVoice 100

PharmaVoice

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

363
363
article thumbnail

Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney

BioPharma Dive

The Cambridge, Massachusetts-based biotech is using what it calls ligand-siRNA conjugates to reach drug targets in the kidney, which historically have been difficult to reach with RNA therapies.

127
127
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Importance of choosing the right POC marketing partners in healthcare

pharmaphorum

Choosing the right POC (point of care) marketing partners in healthcare is crucial for reaching healthcare professionals (HCP) effectively. Learn about the importance and benefits of selecting the right partners in this essential marketing strategy.

122
122
article thumbnail

STAT+: 7 children developed blood cancer after Bluebird Bio gene therapy for rare neurological disease

STAT

Newly published data show that seven out of 67 children who received Bluebird Bio’s gene therapy for a devastating neurological disorder in clinical trials have since gone on to develop blood cancers.  That means four additional patients have developed blood cancers since June 2022, when concerns about three cancer cases prompted the Food and Drug Administration to hold a hearing of outside advisers before approving the treatment, marketed as Skysona.

Hospitals 363

More Trending

article thumbnail

Ex-Pfizer execs ‘threatened’ for supporting plans to shake up company, Starboard says

BioPharma Dive

In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.

124
124
article thumbnail

Advancing Precision Care For All

pharmaphorum

Advancing Precision Care For All with Hakim Yadi from Closed Loop Medicine. Listen to the latest podcast episode featuring insights from a leader in the healthcare industry.

124
124
article thumbnail

STAT+: A pariah in science, the ‘CRISPR babies’ researcher gains support from a U.S. cryptocurrency entrepreneur

STAT

On June 17, He Jiankui received an email that wasted no time getting to the point: An American cryptocurrency entrepreneur had learned about the Chinese scientist’s recent proposal to use CRISPR gene-editing technology on human embryos to lower their future risk of developing Alzheimer’s disease, and he was offering funding and other help to turn those plans into a new commercial venture. He rose to international infamy in 2018, when it came to light that he

363
363
article thumbnail

Novo’s GLP-1 Wegovy could improve heart health for millions more than previously thought, AI study finds

PharmaVoice

Through real-world data, an AI company found that popular weight loss drugs could be a preventive measure for patients at risk of heart attack and stroke.

258
258
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Sanofi may have found a buyer for its consumer health business

BioPharma Dive

The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD&R, in a deal that reportedly could be worth more than $16 billion.

118
118
article thumbnail

The future of multiple myeloma is personalised, but we must work together to deliver it

pharmaphorum

The future of multiple myeloma treatment is personalised, but collaboration is essential to deliver it. Learn about the latest advancements and how working together can improve outcomes for patients.

119
119
article thumbnail

Sammy Basso, progeria advocate, has died at 28

STAT

We generally don’t think of rare-disease advocacy as funny. But of the many qualities apparent to anyone who met Sammy Basso, a biologist and spokesperson for the progeria patient community, who died suddenly on Saturday at 28, perhaps the most disarming was his ability to find laughter in almost anything. One April Fool’s Day, he posted a video about his doctors putting him on a diet — an absurdity for someone whose genetic disorder prevented him from gaining weight.

364
364
article thumbnail

As AI transforms drug development, biotechs might not need as much Big Pharma support

PharmaVoice

Small biotechs are making gains with AI drug development, and their advantages may help some push ahead without Big Pharma.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Aurigene Oncology announces phase 1 results for India’s first CAR-T cell therapy in multiple Myeloma

Express Pharma

Aurigene Oncology, a subsidiary of Dr Reddy’s Laboratories, has released the Phase 1 results for Ribrecabtagene autoleucel (DRL-1801), a BCMA-directed CAR-T cell therapy, from the SWASTH study. This trial marks India’s first use of novel autologous CAR-T cell therapy in patients with relapsed or refractory multiple myeloma. The study presented data from the first eight patients enrolled.

111
111
article thumbnail

Unpacking EASD 2024: Key themes, topics, and influencers

pharmaphorum

Stay updated on the latest insights from EASD 2024 with a comprehensive breakdown of key themes, topics, and influencers. Learn more about the essential information you need to know.

122
122
article thumbnail

2024 Nobel prize in medicine: Ruvkun, Ambros win for discovery of microRNA

STAT

LONDON — A pair of scientists who discovered a type of RNA molecule that helps control the activity of genes — allowing our cells to perform all their myriad of functions in different tissues throughout the body — won the 2024 Nobel Prize in medicine or physiology on Monday. The award went to Victor Ambros and Gary Ruvkun for their research into microRNA, which the Nobel committee described as a “groundbreaking discovery [that] revealed a completely new principle of g

363
363
article thumbnail

AI startup Basecamp allies with the Broad to dream up ‘programmable’ genetic medicines

BioPharma Dive

The company, which is building a database of biological interactions found in nature, revealed $60 million in funding and a collaboration with David Liu’s lab.

116
116
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

CPHI Milan 2024: What Does the Future Pharma Workforce Look Like?

PharmaTech

Five speakers discussed the impact of the COVID-19 pandemic, the rise of artificial intelligence, more women in leadership tracks in the industry, and various emerging technologies.

109
109
article thumbnail

Mpox shows need for new approaches to therapeutic antibody research

pharmaphorum

The recent Mpox outbreak highlights the urgent need for new approaches to therapeutic antibody research. Discover how the World Health Organization (WHO) and CDC are responding to this public health crisis.

117
117
article thumbnail

Opinion: Encampment sweeps threaten homeless people’s health

STAT

Recently, California Gov. Gavin Newsom granted $130.7 million for local governments addressing homelessness, including clearing encampments. It comes in the wake of  a June Supreme Court ruling that gave cities full authority to implement and enforce policies that would allow them to clear encampments as they see fit. In early August, Newsom was even filmed removing homeless people’s belongings from public view in Mission Hills in Los Angeles County.

Cart Fill 363
article thumbnail

Aerogen and Indian Association of Respiratory Care sign MoU to advance respiratory therapy education in India

Express Pharma

Aerogen, a global leader in acute-care aerosol drug delivery based in Ireland, and the Indian Association of Respiratory Care (IARC) have signed a Memorandum of Understanding (MoU) to advance respiratory therapy education and improve patient care throughout India. This collaboration focuses on elevating respiratory services and outcomes across the country.

Hospitals 105
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Fewer than one in ten community pharmacists can prescribe, NHSE suggests

The Pharmacist

Around 8% of community pharmacists in England were qualified as independent prescribers (IPs) in 2023, an NHS England workforce survey has suggested. In 2023, around 2,217 community pharmacists were IP qualified, or around 8% of the total community pharmacist workforce - an estimated 27,485, according to the latest data from the Community Pharmacy Workforce survey. […] The post Fewer than one in ten community pharmacists can prescribe, NHSE suggests appeared first on The Pharmacist.

article thumbnail

Weight loss gold rush: Developers vie for next blockbuster treatment

pharmaphorum

Discover the latest advancements in weight loss treatments as developers race to create the next blockbuster solution. Stay informed about the cutting-edge options available.

117
117
article thumbnail

STAT+: Medical journal peer reviewers are paid millions by industry, study finds

STAT

Nearly 60% of the experts who reviewed manuscripts for four prominent medical journals received at least one payment from industry during a recent three-year period and, overall, these reviewers or their institutions received more than $1 billion from companies, according to a new analysis. Between 2020 and 2022, 1,155 of the 1,962 experts who reviewed studies for The BMJ, JAMA, The Lancet, and The New England Journal of Medicine received some form of payment.

article thumbnail

Capsules of controversy: India’s growing appetite for dietary supplements

Express Pharma

The Food Safety and Standards Authority of India (FSSAI) uncovered a rather disturbing trend last year. A nationwide enforcement drive revealed that over 15 per cent of tested health supplement samples failed to meet regulatory standards. This revelation highlights the growing pains of a sector that promises health benefits to millions of consumers.

Labelling 105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

First real-world study reveals encouraging efficacy for cell therapy

European Pharmaceutical Review

New results from a first-of-its-kind study reports that a CAR-T cell therapy provided similar efficacy and safety to relapsed or refractory multiple myeloma patients administered with the treatment in clinical trials. For example, of the 236 patients who received infusions of ciltacabtagene autoleucel (cilta-cel), data shows that 89 percent responded to the treatment.

105
105
article thumbnail

Scholar Rock preps filings after SMA antibody clears trial

pharmaphorum

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings in early 2025.The stock rocketed 362% after the announcement, taking Scholar Rock's market cap above $2.7 billion, as analysts started to talk about a blockbuster sales opportunity for the selective myostatin inhibitor.

111
111
article thumbnail

STAT+: As U.S. efforts stall, China pushes ahead with CRISPR treatments for muscular dystrophy

STAT

Two of the first efforts to treat Duchenne muscular dystrophy with CRISPR gene editing are getting off the ground in China, even as projects in the U.S. have seemingly stalled. Trials for the fatal muscle-wasting disease were started in the last couple of months by two different Chinese companies. One, GenAssist, has already dosed one young boy. Huidagene, the other biotech, expects to dose the first of three boys soon and report data by Q1 next year.

355
355
article thumbnail

CDSCO committee recommends Wockhardt’s novel antibiotic Miqnaf for CABP treatment

Express Pharma

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has provided a recommendation for Wockhardt’s novel antibiotic Miqnaf (nafithromycin) for the treatment of Community-Acquired Bacterial Pneumonia (CABP) in adults. The SEC recommendation is based on a comprehensive review of the product dossier, which includes non-clinical, US/EU Phase 1, Global Phase 2, and India Phase 3 clinical studies conducted over the last 15 years.

105
105
article thumbnail

Pharmacy First 'good starting point' for PA scope of practice, says RCGP

The Pharmacist

The clinical pathways delivered under Pharmacy First are a 'good starting point' to define the scope of practice for Physician Associates (PAs), the Royal College of GPs (RCGP) has said. Pharmacists must undertake additional training to deliver minor ailments consultations under Pharmacy First. But the RCGP suggested that 'first point of contact presentations' of over […] The post Pharmacy First 'good starting point' for PA scope of practice, says RCGP appeared first on The Pharm

112
112